Proteasome Inhibitor
16 drugs across 14 manufacturers|15 Generic,1 Brand
The Proteasome Inhibitor class contains 16 NDCs from 14 manufacturers (15 generic, 1 brand), at an average NADAC of $134.90 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
16
15G / 1B
Manufacturers
14
Avg $134.9001/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 16 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
14 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 2 more manufacturers
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VELCADE 3.5 MG VIAL bortezomib | $1508.2109 per EA | — |
BORTEZOMIB 3.5 MG VIAL bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL BORTEZOMIB | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL BORTEZOMIB | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
BORTEZOMIB 3.5 MG VIAL Bortezomib | $43.3460 per EA | — |
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
BluePoint Laboratories manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Bortezomib market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Proteasome Inhibitor class?
The Proteasome Inhibitor class contains 16 NDCs from 14 manufacturers — 15 generic and 1 brand product.
What is the average price of Proteasome Inhibitor drugs?
The average NADAC for the Proteasome Inhibitor class is $134.9001 per unit across 16 NDCs.
Is generic cheaper than brand in the Proteasome Inhibitor class?
Among products priced per EA, the average generic NADAC in this class is $43.3460, versus $1508.2109 for brand — brand products average about 35× the generic price.
Which manufacturers make Proteasome Inhibitor drugs?
14 manufacturers make drugs in the Proteasome Inhibitor class. Ranked by number of NDCs, the largest are BluePoint Laboratories (3), Takeda Pharmaceuticals America, Inc. (1), Hikma Pharmaceuticals USA Inc. (1), Hospira Inc. (1), Camber Pharmaceuticals Inc. (1).